Six Overlaps, No Owner: Where AI Governance Actually Breaks Down

AI governance rarely fails because an organization lacks capable executives. It fails because capable executives share responsibility without naming who has authority to decide.
At the board level, the problem is straightforward: directors do not need to make the operating decision, but they do need to see that a named owner exists. After 20 years of board governance, including five years as a chairman, I have seen how quickly shared responsibility turns into shared ambiguity when that ownership is missing.
Our healthcare AI governance work focuses on making those structural risks visible to boards and executive teams before adoption outruns accountability.
The four mandates
- CEO: direction and accountability
- CIO: enterprise adoption
- CTO: engineering and innovation
- CISO: security and resilience
The problem appears between these roles, not within them.

The six overlaps
1. CEO and CIO: transformation and return on investment
The unowned decision is whether an AI initiative is producing the operational or clinical value that justified the investment.
2. CEO and CTO: innovation and growth
The unowned decision is whether a technical opportunity is important enough to fund, scale, or move from experiment into operating dependence.
3. CEO and CISO: governance and risk
The unowned decision is who can accept, escalate, pause, or reject an AI risk when it rises to an enterprise issue in a healthcare setting.
4. CIO and CTO: platform and architecture
The unowned decision is who has final authority when a promising AI capability must be integrated, supported, and moved into production.
5. CIO and CISO: enterprise control
The unowned decision is who owns implementation and reporting when access, monitoring, vendor, or resilience controls are required.
6. CTO and CISO: secure AI engineering
The unowned decision is who can approve deployment when security testing, safeguards, or remediation leave material issues unresolved.
The practical board test
For every material AI initiative, I recommend a one-page decision-rights record. The point is not more process; it is to make ownership visible before an exception, failure, or dispute forces the issue.
It should state:
- Who decides
- Who executes
- Who must be consulted
- What triggers escalation
Resolve the overlap before it becomes a failure
In healthcare AI governance, responsibility should be shared. Strategic, technical, operational, and security perspectives all belong in the process, but shared responsibility still has to convert into clear decision rights.
The board does not own the operating decision. It must be able to see that a named owner exists, that the owner can act, and that escalation is defined when the decision crosses risk limits.
Start a conversation about board-level AI governance and risk.